GO
Loading...

Lightning Round: Citigroup, Savient Pharmaceuticals and More

Monday, 2 May 2011 | 7:57 PM ET

Savient Pharmaceuticals: Cramer said he would like to do some homework and see the first quarter revenue results before talking about this biopharmaceutical company. He will address it at a future date.

Citigroup : While Cramer likes CEO Vikram Pandit, he does not like any bank stocks at this time.

Lightning Round
You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.

“Our government does not like the way banks do business in this country,” Cramer complained. "The headwinds from the government remain way, way too difficult."

American Capital : This asset management name is “way too risky for me,” Cramer said. If he had to own a money manager, he would go with Kohlberg Kravis Roberts .













Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

  Price   Change %Change
ACAS
---
C
---
KKR
---
SVNTQ
---
KFN
---

Contact Mad Money

  • Showtimes

    Monday - Friday 6p ET
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.